LivaNova (LIVN) Divestments (2018 - 2021)

LivaNova (LIVN) posted Divestments of $2.7 million for Q4 2021, up 278.28% sequentially from -$1.5 million in Q3 2021.

LivaNova (LIVN) Divestments (2018 - 2021) Analysis & Trends

LivaNova has reported Divestments for 2 years, with the latest figure at $2.7 million in Q4 2021.

Quarterly Divestments changed N/A year-over-year to $2.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2022 was $1.2 million (down 94.02% YoY) and the FY2021 annual result came in at $42.9 million, changed N/A from the prior year.
Divestments grew to $2.7 million in Q4 2021 per LIVN's latest filing, from -$1.5 million in the prior quarter.
Over five years, Divestments peaked at $173.4 million in Q2 2018 and troughed at -$1.5 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	200.11 Bn	194.51 Bn	7.27 Bn	-
2	Stryker	129.85 Bn	126.37 Bn	4.50 Bn	-
3	Medtronic	119.93 Bn	110.71 Bn	6.41 Bn	-
4	Boston Scientific	74.18 Bn	73.64 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.54 Bn	48.29 Bn	1.35 Bn	-
6	Dexcom	34.76 Bn	32.81 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.25 Bn	32.14 Bn	2.18 Bn	-
8	Koninklijke Philips	26.45 Bn	23.13 Bn	4.55 Bn	153.43 Mn
9	Steris	23.29 Bn	22.80 Bn	684.20 Mn	-
10	LivaNova	4.33 Bn	3.81 Bn	273.67 Mn	-

Download Data